Work

Beyond Cetuximab for Head and Neck Cancer: Dual Target Antibody Blockade of EGFR and HER3 Enhances Radiosensitivity and Overcomes Acquired Resistance to EGFR Inhibitors

Year: 2011

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2011.06.156

Authors: P.M. Harari, S. Huang, C. Li, M.X. Sliwkowski

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Genentech

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2092946571

FWCI:

Cites:

Cited by:

Related to: 10